Jolieke van Oosterwijk

Jolieke van Oosterwijk

UNVERIFIED PROFILE

Are you Jolieke van Oosterwijk?   Register this Author

Register author
Jolieke van Oosterwijk

Jolieke van Oosterwijk

Publications by authors named "Jolieke van Oosterwijk"

Are you Jolieke van Oosterwijk?   Register this Author

13Publications

263Reads

46Profile Views

Sexually dimorphic tumor suppression by small mitochondrial .

Oncotarget 2019 Feb 8;10(12):1235-1237. Epub 2019 Feb 8.

Department of Tumor Cell Biology, St. Jude Children's Research Hospital, Memphis, TN, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18632/oncotarget.26651DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6383814PMC
February 2019

Small mitochondrial Arf (smArf) protein corrects p53-independent developmental defects of tumor suppressor-deficient mice.

Proc Natl Acad Sci U S A 2017 07 26;114(28):7420-7425. Epub 2017 Jun 26.

Howard Hughes Medical Institute, Department of Tumor Cell Biology, St. Jude Children's Research Hospital, Memphis, TN 38105;

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1073/pnas.1707292114DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5514764PMC
July 2017

An orthotopic mouse model for chondrosarcoma of bone provides an in vivo tool for drug testing.

Virchows Arch 2015 Jan 21;466(1):101-9. Epub 2014 Oct 21.

Department of Pathology, Leiden University Medical Center, Albinusdreef 2, 2333ZA, Leiden, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00428-014-1670-yDOI Listing
January 2015

Update on targets and novel treatment options for high-grade osteosarcoma and chondrosarcoma.

Hematol Oncol Clin North Am 2013 Oct 26;27(5):1021-48. Epub 2013 Aug 26.

Department of Pathology, Leiden University Medical Center, PO Box 9600, L1-Q, Leiden RC 2300, The Netherlands.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S08898588130010
Publisher Site
http://dx.doi.org/10.1016/j.hoc.2013.07.012DOI Listing
October 2013

Functional profiling of receptor tyrosine kinases and downstream signaling in human chondrosarcomas identifies pathways for rational targeted therapy.

Clin Cancer Res 2013 Jul 28;19(14):3796-807. Epub 2013 May 28.

Ludwig Center at Dana-Farber/Harvard and Center for Sarcoma and Bone Oncology, Department of Medical Oncology, Harvard Medical School, Boston, Massachusetts 02215, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-12-3647DOI Listing
July 2013

Cartilage tumour progression is characterized by an increased expression of heparan sulphate 6O-sulphation-modifying enzymes.

Virchows Arch 2012 Oct 18;461(4):475-81. Epub 2012 Aug 18.

Department of Pathology, Leiden University Medical Center, Albinusdreef 2, L1-Q, 2300 RC Leiden, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00428-012-1300-5DOI Listing
October 2012

Kinome profiling of chondrosarcoma reveals SRC-pathway activity and dasatinib as option for treatment.

Cancer Res 2009 Aug 14;69(15):6216-22. Epub 2009 Jul 14.

Department of Pathology and Orthopedic Surgery, Leiden University Medical Center, Leiden, the Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-08-4801DOI Listing
August 2009